Related Experiment Video

Updated: Jun 21, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

[State of cellular and humoral immunity in patients with stable angina]

V H Lyzohub, O V Savchenko, O M Bondarchuk

    Likars'Ka Sprava
    |August 11, 2009
    PubMed

    Insights

    Patients with stable angina show altered immune cell counts, including lower CD3+ T-lymphocytes and a reduced helper/suppressor ratio. These immune changes correlate with cholesterol and white blood cell levels, suggesting a new classification approach.

    Area of Science:

    • Immunology
    • Cardiology

    Background:

    • Stable angina (stenocardia) affects numerous patients, with its underlying immunological mechanisms requiring further elucidation.
    • Understanding immune system alterations in stable angina is crucial for developing novel diagnostic and prognostic tools.

    Purpose of the Study:

    • To analyze immunogenetic markers in patients with stable angina.
    • To investigate the relationship between immunological indicators and clinical parameters like cholesterol and leukocytosis.

    Main Methods:

    • Analysis of immunogenetic test indicators in 104 patients with stable angina (Functional Classes I-III).
    • Measurement of CD3+ T-lymphocytes, CD4+/CD8+ ratio, and circulating immune complexes.
    • Correlation analysis with cholesterol and leukocyte levels.

    Main Results:

    • Patients exhibited lower CD3+ T-lymphocyte counts and a decreased T-helper/T-suppressor (CD4+/CD8+) cell ratio.
    • Elevated concentrations of circulating immune complexes were observed.
    • These immunological changes were independent of angina functional class and history of myocardial infarction.
    • A significant correlation was found between immunological markers and levels of cholesterol and leukocytosis.

    Conclusions:

    • Stable angina is associated with specific immunogenetic alterations, including reduced T-lymphocyte levels and increased immune complexes.
    • The strong correlation between immune markers, cholesterol, and leukocytes suggests a potential for a new classification system for angina patients.
    • This approach may offer a more comprehensive understanding of the disease pathophysiology.

    More Related Videos

    Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells12:46

    Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

    Published on: August 17, 2022

    Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders06:39

    Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

    Published on: August 18, 2016

    Related Concept Videos

    Angina III: Clinical Manifestations and Assessment01:29

    Angina III: Clinical Manifestations and Assessment

    Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
    Angina V: Nursing Management01:20

    Angina V: Nursing Management

    Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
    Angina II: Classification01:27

    Angina II: Classification

    Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
    Angina IV: Management01:26

    Angina IV: Management

    IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
    Angina I: Introduction01:30

    Angina I: Introduction

    Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
    Myocarditis III: Medical Management01:14

    Myocarditis III: Medical Management

    Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...